Healthcare provider profile · identity verified

Yaneiky Marquez, ARNP

Nurse Practitioner · MIAMI, FL · NPI 1689289043

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	441	139
Losartan Potassium	Losartan Potassium	409	124
Simvastatin	Simvastatin	359	101
Hydrochlorothiazide	Hydrochlorothiazide	330	101
Alendronate Sodium	Alendronate Sodium	281	88
Gabapentin	Gabapentin	281	94
Levothyroxine Sodium	Levothyroxine Sodium	266	76
Metformin Hcl	Metformin Hcl	256	79
Lisinopril	Lisinopril	197	66
Amlodipine Besylate	Amlodipine Besylate	187	64
Vitamin D2	Ergocalciferol (Vitamin D2)	157	56
Tamsulosin Hcl	Tamsulosin Hcl	150	48
Latanoprost	Latanoprost	130	30
Glipizide	Glipizide	129	40
Albuterol Sulfate Hfa	Albuterol Sulfate	127	46
Escitalopram Oxalate	Escitalopram Oxalate	125	45
Azithromycin	Azithromycin	122	97
Mirtazapine	Mirtazapine	115	48
Rosuvastatin Calcium	Rosuvastatin Calcium	115	47
Montelukast Sodium	Montelukast Sodium	114	40
Famotidine	Famotidine	113	54
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	110	28
Metoprolol Succinate	Metoprolol Succinate	108	38
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	106	19
Metoprolol Tartrate	Metoprolol Tartrate	105	38
Furosemide	Furosemide	104	36
Donepezil Hcl	Donepezil Hcl	103	42
Trazodone Hcl	Trazodone Hcl	99	32
Ciclopirox	Ciclopirox	94	31
Baclofen	Baclofen	88	64
Memantine Hcl	Memantine Hcl	87	35
Sildenafil Citrate	Sildenafil Citrate	86	18
Methylprednisolone	Methylprednisolone	78	50
Pantoprazole Sodium	Pantoprazole Sodium	78	42
Alprazolam	Alprazolam	73	21
Meloxicam	Meloxicam	73	53
Omeprazole	Omeprazole	73	38
Clonazepam	Clonazepam	70	16
Ibuprofen	Ibuprofen	70	53
Eliquis	Apixaban	68	14
Buspirone Hcl	Buspirone Hcl	66	12
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	66	17
Quetiapine Fumarate	Quetiapine Fumarate	64	21
Sertraline Hcl	Sertraline Hcl	64	30
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	63	42
Finasteride	Finasteride	63	20
Clopidogrel	Clopidogrel Bisulfate	61	22
Synthroid	Levothyroxine Sodium	58	suppressed
Lorazepam	Lorazepam	56	suppressed
Carvedilol	Carvedilol	50	19
Azelastine Hcl	Azelastine Hcl	49	24
Ciprofloxacin Hcl	Ciprofloxacin Hcl	48	44
Meclizine Hcl	Meclizine Hcl	48	32
Mupirocin	Mupirocin	48	41
Insulin Aspart Flexpen	Insulin Aspart	44	suppressed
Duloxetine Hcl	Duloxetine Hcl	43	17
Fluticasone Propionate	Fluticasone Propionate	43	23
Hydralazine Hcl	Hydralazine Hcl	43	13
Temazepam	Temazepam	42	11
Folic Acid	Folic Acid	40	12
Ketoconazole	Ketoconazole	40	18
Methocarbamol	Methocarbamol	39	27
Ammonium Lactate	Ammonium Lactate	37	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	36	28
Levofloxacin	Levofloxacin	36	30
Timolol Maleate	Timolol Maleate	35	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	33	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	12
Brimonidine Tartrate	Brimonidine Tartrate	30	suppressed
Ciclopirox	Ciclopirox Olamine	30	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	30	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	30	suppressed
Diclofenac Sodium	Diclofenac Sodium	29	20
Pradaxa	Dabigatran Etexilate Mesylate	29	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	28	11
Allopurinol	Allopurinol	27	15
Spironolactone	Spironolactone	27	suppressed
Warfarin Sodium	Warfarin Sodium	27	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	24	16
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Alogliptin	Alogliptin Benzoate	22	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Naproxen	Naproxen	22	15
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Atenolol	Atenolol	20	suppressed
Valsartan	Valsartan	20	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	18	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Novolog Flexpen	Insulin Aspart	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Cilostazol	Cilostazol	16	suppressed
Sps	Sodium Polystyrene Sulfon/Sorb	16	13
Unifine Pentips	Pen Needle, Diabetic	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Prednisone	Prednisone	15	suppressed
Benzonatate	Benzonatate	14	13
Clonidine Hcl	Clonidine Hcl	14	suppressed
Dapagliflozin	Dapagliflozin Propanediol	14	suppressed
Lactulose	Lactulose	14	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	14	12
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Irbesartan	Irbesartan	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Vesicare	Solifenacin Succinate	12	suppressed
Acyclovir	Acyclovir	11	11
Advair Diskus	Fluticasone Propion/Salmeterol	11	suppressed
Bimatoprost	Bimatoprost	11	suppressed
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	11	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	11	suppressed
Cephalexin	Cephalexin	11	11
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Risperidone	Risperidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error